fbpx Skip to content

Eriocitrin: The Powerful Flavonoid from Lemons and its Impact on Health

ERIOCITRIN

Eriocitrin, a flavonoid primarily found in lemons, is noted for its unique properties. Flavonoids are natural compounds known for their health benefits, present in many fruits and vegetables. This article explores the multiple facets of eriocitrin, from its antioxidant properties to its potential in fighting chronic diseases.

Index

    Pharmacological Properties of Eriocitrin

    Antioxidants:

    Eriocitrin is a potent antioxidant, meaning it helps combat cell damage caused by free radicals. This is vital for keeping the body healthy and preventing aging-related diseases.

    Anticancer:

    Studies have indicated that eriocitrin might have protective effects against certain types of cancer, offering a promising path for future therapies.

    Antidiabetic and Anti-inflammatory:

    It shows potential in reducing inflammation and controlling blood sugar levels, which is crucial for diabetes treatment.

    In the Bone and Cardiovascular System:

    Additionally, it is suggested that it could benefit bone and cardiovascular health, further broadening its range of beneficial applications.

    Slide
    punicalagina-plus-es

    Eriocitrin Pharmacokinetics and Metabolism:

    The way the body absorbs and utilizes eriocitrin is key to its effectiveness. This flavonoid demonstrates good bioavailability, meaning the body can efficiently use it.

    Eriocitrin Cytoprotective and Nephroprotective Effects:

    It has shown protective effects on the kidneys, suggesting its use in the treatment of renal diseases.

    Eriocitrin Neuroprotective Effects:

    Likewise, its potential to protect the nervous system opens new possibilities in the treatment of neurodegenerative diseases.

    Eriocitrin and Inflammatory Diseases:

    Inflammation is a common factor in many chronic diseases. Eriocitrin, with its anti-inflammatory properties, could be a valuable tool in managing these conditions, as seen in various studies.

    Metabolism and Diabetes:

    Managing diabetes is a global challenge:

    Eriocitrin could play a significant role in this aspect, helping to regulate sugar metabolism in the body and improving insulin resistance.

    Conclusions:

    Eriocitrin is much more than just a simple component of lemons. With a wide range of beneficial effects and its potential in various therapeutic applications, this flavonoid deserves special attention. As science progresses, we are likely to discover even more about this fascinating compound and its applications in human health.

    REFERENCES EROCITRIN RESEARCH

    Eriocitrin: A review of pharmacological effects

    • F. Mehranfar, A.-K. Bordbar, H. Parastar, A combined spectroscopic, molecular
      docking and molecular dynamic simulation study on the interaction of quercetin
      with β-casein nanoparticles, J. Photochem. Photobiol. B Biol. 127 (2013) 100–107.
    • M. Sato, et al., Varietal differences in the phenolic content and superoxide radical
      scavenging potential of wines from different sources, J. Agric. Food Chem. 44 (1)
      (1996) 37–41.
    • N.C. Cook, S. Samman, Flavonoids—chemistry, metabolism, cardioprotective
      effects, and dietary sources, J. Nutr. Biochem. 7 (2) (1996) 66–76.
    • F.D. Dakora, Plant flavonoids: biological molecules for useful exploitation, Funct.
      Plant Biol. 22 (1) (1995) 87–99.
    • A. Das, J. Wang, E. Lien, Carcinogenicity, mutagenicity and cancer preventing
      activities of flavonoids: a structure-system-activity relationship (SSAR) analysis,
      Prog. Drug Res./Fortschritte der Arzneim./Prog. Des. Rech. Pharm. (1994)
      133–166.
    • R. Ficarra, et al., Leaf extracts of some Cordia species: analgesic and antiinflammatory activities as well as their chromatographic analysis, Farmaco 50 (4)
      (1995) 245–256.
    • Y. Miyake, K. Yamamoto, T. Osawa, Isolation of eriocitrin (eriodictyol 7-rutinoside)
      from lemon fruit (Citrus limon BURM. f.) and its antioxidative activity, Food Sci.
      Technol. Int. 3 (1) (1997) 84–89.
    • Y. Miyake, et al., Lipid-lowering effect of eriocitrin, the main flavonoid in lemon
      fruit, in rats on a high-fat and high-cholesterol diet, J. Food Sci. 71 (9) (2006)
      S633–S637.
    • Y. Nogata, et al., Isolation of eriocitrin (eriodictyol 7–O-rutinoside) as an
      arachidonate lipoxygenase inhibitor from Lumie fruit (Citrus lumia) and its
      distribution in Citrus species, J. Sci. Food Agric. 87 (1) (2007) 82–89.
    • X. Cao, et al., Elucidating the interaction mechanism of eriocitrin with β-casein by
      multi-spectroscopic and molecular simulation methods, Food Hydrocoll. 94 (2019)
      63–70.
    • L. Wang, et al., A new graphene nanocomposite modified electrode as efficient
      voltammetric sensor for determination of eriocitrin, J. Electroanal. Chem. 785
      (2017) 96–102.
    • K.-i Minato, et al., Lemon flavonoid, eriocitrin, suppresses exercise-induced
      oxidative damage in rat liver, Life Sci. 72 (14) (2003) 1609–1616.
    • S. Mahejabeen, P. Nirmala, Isolation of Eriocitrin (eriodictyol 7–O-rutinoside) from
      orange (citrus sinuses) peel by using reverse phase HPLC, Int. J. Sci. Res. 6 (8)
      (2017) 3.
    • M. Reinking, Tendinopathy in athletes, Phys. Ther. Sport 13 (1) (2012) 3–10.
      J.-F. Kaux, et al., Current opinions on tendinopathy, J. Sports Sci. Med. 10 (2)
      (2011) 238.
    • C. Shang, et al., Effect of eriocitrin on cell proliferation, apoptosis, migration, and
      scar formation-related genes expression in tendon stem cells, Dokl. Biochem.
      Biophys. 500 (2021) 402–407.
    • Wan, et al., Antiatherosclerotic activity of eriocitrin in high-fat-diet-induced
      atherosclerosis model rats, J. Environ. Pathol. Toxicol. Oncol. Off. Organ Int. Soc.
      Environ. Toxicol. Cancer 39 (1) (2020) 61–75.
    • Y. Fukuchi, et al., Lemon polyphenols suppress diet-induced obesity by upregulation of mRNA levels of the enzymes involved in β-oxidation in mouse white adipose tissue, J. Clin. Biochem. Nutr. 43 (3) (2008) 201–209.
    Configuración